[1] |
Bai H.Design,synthesis and antibacterial activity of antisense peptide nucleic acid targeting bacterial RNA polymerase primary σ70[D].Xi′an:the Fourth Military Medical University,2011.
|
[2] |
Zimmermann TS, Lee AC, Akinc A, et al. RNAi-mediated gene silencing in non-human primates[J].Nature,2006,441(7089):111-114.
|
[3] |
Semple SC,Akinc A,Chen J,et al.Rational design of cationic lipids for siRNA delivery[J].Nat Biotechnol,2010,28(2):172-176.
|
[4] |
Miller AD.Delivery of RNAi therapeutics:work in progress[J].Expert Rev Med Devices,2013,10(6):781-811.
|
[5] |
Zhou YD,Li J.Cationic liposome used as gene vector:materials and preparation techniques[J].Prog Pharm Sci(药学进展),2009,33(7):297-304.
|
[6] |
Kanasty R, Dorkin JR, Vegas A, et al. Delivery materials for siRNA therapeutics[J].Nat Mater,2013,12(11):967-977.
|
[7] |
Miller AD.Delivering the promise of small ncRNA therapeutics[J].Ther Deliv,2014, 5(5):569-589.
|
[8] |
Kolli S,Wong SP,Harbottle R,et al.pH-triggered nanoparticle mediated delivery of siRNA to liver cells in vitro and in vivo[J].Bioconjug Chem,2013, 24(3):314-332.
|
[9] |
Kenny GD,Kamaly N,Kalber TL,et al.Novel multifunctional nanoparticle mediates siRNA tumour delivery,visualisation and therapeutic tumour reduction in vivo[J].J Control Release,2011, 149(2):111-116.
|
[10] |
Medina-Kauwe LK,Xie J,Hamm-Alvarez S.Intracellular trafficking of nonviral vectors[J].Gene Ther,2005, 12(24):1734-1751.
|
[11] |
Kang MR,Yang G,Place RF,et al.Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth[J].Cancer Res,2012, 72(19):5069-5079.
|
[12] |
Guo J,Cahill MR,McKenna SL,et al.Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia[J].Biotechnol Adv,2014, 32(8):1396-1409.
|
[13] |
Kajimoto K,Sato Y,Nakamura T,et al.Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo[J].J Control Release,2014,190:593-606.
|
[14] |
Haynes M,Huang L.Hepatic RNA interference:delivery by synthetic vectors[J].Drug Deliv Transl Res,2014,4(1):61-73.
|
[15] |
Hobo W,Novobrantseva TI,Fredrix H,et al.Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation[J].Cancer Immunol Immunother,2013, 62(2):285-297.
|